An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Postmarket Drug Safety Information for Patients and Providers

Vardenafil hydrochloride (marketed as Levitra) Information

To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.

Related Information

Regulatory History of Verdenafil from Drugs@FDA
Information for Healthcare Professionals: Sildenafil (marketed as Viagra and Revatio), Vardenafil (marketed as Levitra), Tadalafil (marketed as Cialis)
FDA Announces Revisions to Labels for Cialis, Levitra and Viagra
Questions and Answers about Viagra, Levitra, Cialis, and Revatio: Possible Sudden Hearing Loss

Historical Information

Vardenafil (marketed as Levitra) Healthcare Professional Sheet (7/2005)
FDA Updates Labeling for Viagra, Cialis and Levitra for Rare Post-Marketing Reports of Eye Problems

Top